SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe
First-ever randomized, placebo-controlled Phase 1 trial - published in The Lancet Microbe - supports SNIPR001’s safety, tolerability, and restriction to the gastrointestinal tract in healthy participants